Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916733 · ClinicalTrials.gov registry record
A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study
A clinical trial, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- 89
- Enrollment target
NCT01916733 is a clinical trial that has completed, run by University of Vermont Medical Center. The registered enrollment target is 89 participants.
The verdict
NCT01916733 has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
The aim of this study is to examine the effect of moderate glucose (blood sugar) control in diabetic and non-diabetic patients undergoing leg bypass surgery (LEB) or open abdominal aortic aneurysm (AAA) repair. We hypothesize that use of Fletcher Allen Health Care's current insulin infusion strategy will result in improved blood sugar control which will translate into decreased postoperative morbidity (fewer complications) and better long term outcomes when compared to patient outcomes at other institutions which utilize other blood sugar management strategies.
Interventions
- DRUG standard insulin protocol post-op (continuous IV insulin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01916733
The ClinicalTrials.gov registry entry for NCT01916733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which standard insulin protocol post-op (continuous IV insulin) is the first listed.
NCT01916733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01916733 about?
NCT01916733 is a clinical study titled "A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study". The aim of this study is to examine the effect of moderate glucose (blood sugar) control in diabetic and non-diabetic patients undergoing leg bypass surgery (LEB) or open abdominal aortic aneurysm (AAA) repair. We hypothesize that use of Fletcher Allen Health Care's current insulin infusion strategy...
What is the current status of trial NCT01916733?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2013-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01916733?
The interventions under investigation include: standard insulin protocol post-op (continuous IV insulin) (DRUG).
Who is sponsoring clinical trial NCT01916733?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.